Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chaulet

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Bulletin of the International Union Against Tuberculosis|January 1, 1976
Controlled therapeutic trial on three second-line chemotherapy regimens (one of short duration) in pulmonary tuberculosisN Ait-Khaled, H Benadjila, M S Loucif, et al.
Bulletin of the International Union Against Tuberculosis|December 1, 1978
[Results of a cooperative international questionnaire on the cost of antitubercular drugs]P Chaulet, A Benachenhou, J P Virot, et al.
Bulletin of the International Union Against Tuberculosis|January 1, 1976
Practical results of standard first-line treatment in pulmonary tuberculosis : influence of primary resistanceK Abderrahim, P Chaulet, N Oussedik, et al.
Revue Des Maladies Respiratoires|January 1, 1990
[A therapeutic trial of a combination of 3 essential drugs in a short course of chemotherapy in tuberculosis. Results 6 months after the end of treatment]D Agounitestane, M Chiheb, S Khaled, et al.
Revue De Tuberculose Et De Pneumologie|June 1, 1970
[Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria]D Larbaoui, P Chaulet, J Grosset, et al.
Revue Roumaine De Virologie (Bucharest, Romania : 1990)|July 1, 1990
[Acute respiratory infections of viral origin in the children of Algiers, Algeria based on a seroepidemiological study]Z Kadi, A Bouguermouh, Z Belhocine, et al.
The New England Journal of Medicine|June 6, 1998
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance SurveillanceA Pablos-Méndez, M C Raviglione, A Laszlo, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Bulletin of the International Union Against Tuberculosis|January 1, 1976
Controlled therapeutic trial on three second-line chemotherapy regimens (one of short duration) in pulmonary tuberculosisN Ait-Khaled, H Benadjila, M S Loucif, et al.
Bulletin of the International Union Against Tuberculosis|December 1, 1978
[Results of a cooperative international questionnaire on the cost of antitubercular drugs]P Chaulet, A Benachenhou, J P Virot, et al.
Bulletin of the International Union Against Tuberculosis|January 1, 1976
Practical results of standard first-line treatment in pulmonary tuberculosis : influence of primary resistanceK Abderrahim, P Chaulet, N Oussedik, et al.
Revue Des Maladies Respiratoires|January 1, 1990
[A therapeutic trial of a combination of 3 essential drugs in a short course of chemotherapy in tuberculosis. Results 6 months after the end of treatment]D Agounitestane, M Chiheb, S Khaled, et al.
Revue De Tuberculose Et De Pneumologie|June 1, 1970
[Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria]D Larbaoui, P Chaulet, J Grosset, et al.
Revue Roumaine De Virologie (Bucharest, Romania : 1990)|July 1, 1990
[Acute respiratory infections of viral origin in the children of Algiers, Algeria based on a seroepidemiological study]Z Kadi, A Bouguermouh, Z Belhocine, et al.
The New England Journal of Medicine|June 6, 1998
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance SurveillanceA Pablos-Méndez, M C Raviglione, A Laszlo, et al.
Pageof 7